Cancer-causing benzene found in Clinique and Clearasil acne treatments
U.S. independent laboratory Valisure detected benzene in products from Estée Lauder's Clinique, Target's Up & Up and Reckitt Benckiser's Clearasil. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging the regulator to recall the product, conduct an investigation and revise industry guidance. The FDA has not yet responded to the petition.
Benzene has also been detected in products including Proactiv, PanOxyl, Walgreens' acne soap bar and Walmart's Equate Beauty acne cream, according to the Connecticut-based company. Valisure's test results indicate that BPO products on the market may form benzene at concentrations more than 800 times the FDA concentration limit.
High levels of benzene were detected not only inside BPO products, but also in the air around incubated BPO products, suggesting benzene may be leaking from some product packaging and posing a potential inhalation risk. Exposure to benzene through inhalation, oral administration, or through the skin may cause cancers such as leukemia and bone marrow blood cancers, as well as potentially life-threatening blood disorders.
The beauty industry has seen a spate of benzene scare recalls related to aerosol products in 2021-22, including dry shampoo and spray sunscreen from brands like Banana Boat; Unilever's Dove and Tresemmé; and Procter & Gamble's Pantene , Aussie and Herbal Essences etc.
However, David Light, co-founder and president of Valisure, says these historic issues are less severe than current BPO acne products and that the culprit is an intentionally added ingredient. “This finding of fundamental instability of benzoyl peroxide and formation of benzene is significantly different from Valisure's previous findings of benzene in sunscreen, hand sanitizer and other consumer products."
"The benzene we find in sunscreen and other consumer products is an impurity from contaminated ingredients; however, the benzene in benzoyl peroxide products comes from benzoyl peroxide itself, sometimes hundreds of times the FDA's conditional limit.
"This means this issue affects benzoyl peroxide products broadly, including prescription and over-the-counter products, and requires urgent action."
2026-09-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Estée Lauder Debuts Clinique on Amazon
-
Natural Color Claims Get Easier
-
FSANZ Advances Caffeine Permission Changes
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
Aldi Expands Its Ingredient Ban
-
IPEC Updates Excipient Qualification Guidance
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
Chemical Tanker Explodes Off Oman Coast, Maritime Security Risk Escalates Again
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
Recommend Reading
-
ANVISA Updates Additive Rules
-
Fertilizer Prices Put U.S. Farmers Under Pressure
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
India Prepares New Seed and Pesticide Laws
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
Business Society’s Market Outlook for Ethyl Acetate on August 13, 2026: Fluctuating Trend
-
International Workers' Day Holiday Notice and Service Arrangement
-
This Week, the Domestic Polymeric MDI Market Showed a Weak Decline (5.6-5.9)
-
Business Society’s Ethanol Market Outlook on August 13, 2026: Clearly Downward
-
Business Society SBR Daily Review: Downside Limited, Next Week Likely to See More Volatility